文献速递淋巴瘤造血干细胞移植与细胞治疗

共刺激结构域决定CAR驱动T细胞功能障碍的不同命运

Costimulatory domains direct distinct fates of CAR-driven T-cell dysfunction.
PubMed 文献 · Blood · 2023-01-01

研究建立体外模型通过慢性CAR激活诱导T细胞功能障碍,发现基于CD28的CAR慢性激活触发经典T细胞耗竭程序,而基于41BB的CAR激活不同分子程序并导向新细胞状态;来自进展性淋巴瘤患者的CAR T细胞证实该新程序激活,且41BB依赖的FOXO3激活直接导致CAR T细胞功能受损。

要点

  • 慢性激活CD28型CAR导致经典T细胞耗竭程序激活和功能障碍细胞产生。
  • 41BB型CAR激活不同分子程序,导向T细胞分化为一种新细胞状态。
  • 41BB依赖的转录因子FOXO3激活直接导致CAR T细胞功能受损。

核心结论

  • 共刺激结构域是CAR驱动T细胞功能衰竭的关键调控因素,需要靶向干预以克服共刺激依赖的功能障碍程序。

研究设计与样本

  • 研究建立并验证了一种通过慢性CAR激活驱动T细胞功能障碍的体外模型。
  • 利用来自一名进展性淋巴瘤患者的CAR T细胞进行验证。

主要发现

  • 基于CD28的CAR慢性激活导致经典T细胞耗竭程序激活,产生具有耗竭标志的功能障碍细胞。
  • 基于41BB的CAR激活不同的分子程序,导向T细胞分化为一种新细胞状态。
  • 来自进展性淋巴瘤患者的CAR T细胞证实了该新程序在失败临床产品中的激活。
  • 41BB依赖的转录因子FOXO3激活直接导致CAR T细胞功能受损。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

T cells engineered to express chimeric antigen receptors (CARs) targeting CD19 have demonstrated impressive activity against relapsed or refractory B-cell cancers yet fail to induce durable remissions for nearly half of all patients treated. Enhancing the efficacy of this therapy requires detailed understanding of the molecular circuitry that restrains CAR-driven antitumor T-cell function. We developed and validated an in vitro model that drives T-cell dysfunction through chronic CAR activation and interrogated how CAR costimulatory domains, central components of CAR structure and function, contribute to T-cell failure. We found that chronic activation of CD28-based CARs results in activation of classical T-cell exhaustion programs and development of dysfunctional cells that bear the hallmarks of exhaustion. In contrast, 41BB-based CARs activate a divergent molecular program and direct differentiation of T cells into a novel cell state. Interrogation using CAR T cells from a patient with progressive lymphoma confirmed the activation of this novel program in a failing clinical product. Furthermore, we demonstrate that 41BB-dependent activation of the transcription factor FOXO3 is directly responsible for impairing CAR T-cell function. These findings identify that costimulatory domains are critical regulators of CAR-driven T-cell failure and that targeted interventions are required to overcome costimulation-dependent dysfunctional programs.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Selli ME, Landmann JH, Terekhova M, et al. Costimulatory domains direct distinct fates of CAR-driven T-cell dysfunction. Blood. 2023. PMID: 37130030. doi:10.1182/blood.2023020100

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。